BioCatalyst

REGN7075, Cemiplimab, Platinum-based doublet chemotherapy, Bevacizumab — catalyst calendar

1 verified catalyst event(s) referencing REGN7075, Cemiplimab, Platinum-based doublet chemotherapy, Bevacizumab, each linked to its official source. Verified as of 2026-06-22.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-08-19
in 2mo
ESTIMATED
 READOUT
A Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination Wi
Phase 1/2 · Advanced Solid Tumors
 REGN REGENERON PHARMACEUTICALS, I REGN7075, Cemiplimab, Platinum-based dou ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.